We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

68 hedge funds and large institutions have $502M invested in Loxo Oncology, Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

95% more capital invested

Capital invested by funds: $258M → $502M (+$244M)

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

33% more funds holding

Funds holding: 5168 (+17)

Holders
68
Holders Change
+17
Holders Change %
+33.33%
% of All Funds
1.78%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
22
Increased
23
Reduced
15
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NIP
26
Nicholas Investment Partners
California
$1.61M +$58.3K +2,172 +4%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.56M +$287K +10,700 +24%
SFM
28
Sphera Funds Management
Israel
$1.28M +$1.21M +45,000 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.14M +$160K +5,974 +18%
GCP
30
GSA Capital Partners
United Kingdom
$1.05M +$996K +37,100 New
BIM
31
BlackRock Investment Management
Delaware
$900K +$62.1K +2,315 +8%
Deutsche Bank
32
Deutsche Bank
Germany
$873K -$413K -15,402 -33%
BCM
33
Bridgeway Capital Management
Texas
$859K +$5.37K +200 +0.7%
Balyasny Asset Management
34
Balyasny Asset Management
Illinois
$784K +$739K +27,550 New
RFC
35
Russell Frank Company
Washington
$766K -$262K -9,775 -27%
TCIM
36
TIAA CREF Investment Management
New York
$757K +$21.6K +805 +3%
Citadel Advisors
37
Citadel Advisors
Florida
$726K +$684K +25,501 New
AA
38
ALPS Advisors
Colorado
$719K +$678K +25,276 New
BA
39
BlackRock Advisors
Delaware
$609K -$393K -14,647 -41%
Renaissance Technologies
40
Renaissance Technologies
New York
$592K +$558K +20,800 New
Two Sigma Investments
41
Two Sigma Investments
New York
$578K +$545K +20,324 New
SIM
42
Spark Investment Management
New York
$534K -$939K -35,000 -65%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$480K +$71.1K +2,651 +19%
Morgan Stanley
44
Morgan Stanley
New York
$475K +$438K +16,324 +4,624%
PP
45
PDT Partners
New York
$422K +$398K +14,831 New
ARTA
46
A.R.T. Advisors
New York
$420K -$290K -10,790 -42%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$401K +$378K +14,100 New
Charles Schwab
48
Charles Schwab
California
$376K +$354K +13,200 New
TA
49
Teachers Advisors
New York
$329K
AQR Capital Management
50
AQR Capital Management
Connecticut
$319K +$301K +11,216 New

LOXO Hedge Fund Activity: Q4 2015 in Review

68 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q4 2015, worth a combined $502M — up 95% from $258M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LOXO positions and 5 closed out — a net gain of 17 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $72.6M. The largest seller was Deerfield Management, cutting an estimated $22.5M.

  • 68 institutional investors held Loxo Oncology, Inc (LOXO) as of Q4 2015, up from 51 in Q3 2015.
  • Funds reported $502M of Loxo Oncology, Inc stock for Q4 2015, up 95% quarter-over-quarter.
  • 22 funds opened new Loxo Oncology, Inc positions in Q4 2015 and 5 closed out, a net change of +17 holders.
  • The largest Loxo Oncology, Inc buyer in Q4 2015 was Fidelity Investments, an estimated $72.6M added.
  • The largest Loxo Oncology, Inc seller in Q4 2015 was Deerfield Management, an estimated $22.5M sold.

Based on aggregated 13F filings for Q4 2015.